New clinical research has identified a blood test that can reveal which women are more likely to respond to a particular treatment for ovarian cancer, known as PARP inhibitor therapy.
KFC Switches From Pepsi to Coca-Cola in Major Beverage Deal
KFC will replace Pepsi with Coca-Cola across its U.S. restaurants by spring 2027, marking a major shift in the fast-food beverage industry.



0 Comments